Immunotherapy has emerged as a groundbreaking approach in treating various types of diseases, particularly cancer. The potential to harness the body's immune system to combat disease has opened new avenues in medical treatment, necessitating a comprehensive understanding for physicians.
Immunotherapy, often referred to as biological therapy, works by boosting or restoring the body's natural defenses against disease. This is accomplished by stimulating the immune system to work harder or smarter, or by providing it with additional components, such as synthetic immune system proteins.
There are several types of immunotherapy including monoclonal antibodies, immune checkpoint inhibitors, cancer vaccines, and non-specific immunotherapies. Each type has a unique mechanism of action, but all aim to enhance the body's immune response against disease.
Immunotherapy has shown significant promise in the field of oncology. It has been effective in treating melanoma, lung cancer, head and neck cancer, bladder cancer, and Hodgkin lymphoma among others. Some immunotherapies have been approved as first-line treatments, while others are used when other treatments have not worked.
Like all treatments, immunotherapy can cause side effects, which can vary from patient to patient. Common side effects include fatigue, cough, nausea, skin rash, and loss of appetite. Physicians must be equipped with strategies to manage these side effects to improve patient comfort and treatment adherence.
Immunotherapy represents a paradigm shift in medical treatment, offering new hope for patients with various diseases. As this field continues to evolve, it is crucial for physicians to stay abreast of the latest developments to provide optimal patient care. Understanding the fundamentals of immunotherapy is the first step in this journey.
1.
Regular physical activity before cancer diagnosis may lower progression and death risks
2.
Medication Self-Injection Embraced by Breast Cancer Patients
3.
Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients
4.
FDA Advisors Split on Regimens for Breast, Prostate Cancers
5.
ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs
1.
RDW-CV vs. MCV: Knowing the Difference Can Help You Better Understand Your Health
2.
Clinical Pathways in Hematology in Clinical Decision-Making
3.
Immune Surveillance Screening for Early Cancer Risk Detection
4.
Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown
5.
AI-Driven Digital Pathology in Oncology: From Histology Images to Predictive Treatment Biomarkers
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
How Advances in Cancer Research Are Improving Treatment Options
2.
Navigating the Complexities of Ph Negative ALL - Part II
3.
Signs and Symptoms of Leukemia
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation